Ibalizumab, sold under the brand name Trogarzo, is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV,...
9 KB (735 words) - 11:45, 12 December 2023
Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 "Trogarzo- ibalizumab injection, solution". DailyMed. 8 April 2020. Retrieved 21 September 2020...
13 KB (513 words) - 14:31, 4 May 2024
Passive antibody therapy (section Ibalizumab)
side effects are diarrhea, vomiting, runny nose and other cold symptoms. Ibalizumab (trade name: Trogarzo) is a new antiviral drug specifically for adults...
27 KB (2,923 words) - 15:03, 4 April 2024
| Z Ia–Il | Im–In | Io–Ip | Iq–Iz ibacitabine (INN) ibafloxacin (INN) ibalizumab (INN) ibandronic acid (INN) ibazocine (INN) ibipinabant (USAN, INN) iboctadekin...
5 KB (286 words) - 05:48, 8 August 2024
Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation: Dostarlimab Other: Ibalizumab Chimeric + humanized Otelixizumab Rozanolixizumab Sutimlimab...
38 KB (4,304 words) - 10:14, 21 July 2024
host cell by blocking one of several targets. Maraviroc, enfuvirtide and Ibalizumab are available agents in this class. Maraviroc works by targeting CCR5...
133 KB (15,717 words) - 02:22, 8 August 2024
human IL-23 Y psoriasis Ianalumab mab human BAFF-R autoimmune hepatitis Ibalizumab Trogarzo mab humanized CD4 Y HIV infection Sintilimab human PD-1 squamous...
135 KB (4,054 words) - 22:35, 2 July 2024
T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120 (Fostemsavir (FTR)) Integrase inhibitors (Integrase...
15 KB (1,230 words) - 02:38, 16 July 2024
Durvalumab AstraZeneca UK unresectable Stage III non-small cell lung cancer Ibalizumab-uiyk Theratechnologies human immunodeficiency virus type 1 (HIV-1) infection...
34 KB (180 words) - 22:09, 8 April 2024
approximate the two membranes. It is also referred to as a "fusion inhibitor." Ibalizumab, a monoclonal antibody that binds to domain 2 of CD4 and interferes with...
9 KB (1,095 words) - 03:47, 25 December 2023
Biotech 7/13/17 subcutaneous fully human IL23 Plaque psoriasis 761061 Link ibalizumab-uiyk Trogarzo TaiMed Biologics 3/6/18 intravenous humanized CD4 HIV 761065...
57 KB (4,072 words) - 11:12, 5 August 2024
J05AX19 Tilorone J05AX21 Pentanedioic acid imidazolyl ethanamide J05AX23 Ibalizumab J05AX24 Tecovirimat J05AX25 Baloxavir marboxil J05AX26 Amenamevir J05AX27...
6 KB (538 words) - 04:59, 18 December 2023
pipeline products that have gained considerable prominence include TNX-355 (Ibalizumab), a unique anti-CD4 antibody for treating AIDS, TNX-650 (Lebrikizumab)...
29 KB (3,591 words) - 17:29, 8 June 2024
resistance to itself. Investigators found that enfuvirtide-resistant and ibalizumab-resistant HIV envelopes remained susceptible to fostemsavir. Conversely...
15 KB (1,293 words) - 07:10, 18 July 2024
T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120 (Fostemsavir (FTR)) Integrase inhibitors (Integrase...
28 KB (2,986 words) - 19:14, 25 April 2024
T-20))◊ CCR5 (Maraviroc (MVC) Vicriviroc†, Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120 (Fostemsavir (FTR)) Integrase inhibitors (Integrase...
3 KB (338 words) - 13:45, 27 July 2023
Vedolizumab Visilizumab Vobarilizumab TGN1412§ Immune activation: Dostarlimab Other: Ibalizumab Chimeric + humanized Otelixizumab Rozanolixizumab Sutimlimab...
2 KB (87 words) - 01:28, 30 May 2023
"Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency...
23 KB (2,878 words) - 15:39, 12 April 2024